Efficacy of Treatment for Obsessive Compulsive Disorder
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of these questionnaires is to give us an overview of how OCD has affected your life and perhaps also to give us some clues about things that may have set you up to experience OCD.
| Condition |
|---|
|
Obsessive Compulsive Disorder |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Retrospective |
| Official Title: | Efficacy of Treatment for Obsessive Compulsive Disorder |
| Estimated Enrollment: | 250 |
| Study Start Date: | May 2003 |
| Study Completion Date: | June 2011 |
For us to evaluate the efficacy of our treatment programs, we are interested in your responses before and after treatment. We use two methods to evaluate the efficacy of our treatments: questionnaires and interviews with a member of the Anxiety Disorders Clinic. As part of standard clinic procedure, each person in the program completes an in-person interview with a staff member who will determine your suitability for treatment. If you have received this questionnaire packet, it is likely that your concerns will be appropriately addressed in the Anxiety Disorders Clinic. The purpose of the questionnaire packet is to assess the severity of your obsessive-compulsive disorder; its impact on your functioning, and factors that may contribute to the onset or maintenance of your OCD (e.g., depression, personal standards). We will ask you to complete this questionnaire again when you have completed your treatment along with a brief telephone interview with a staff member of the Anxiety Disorders Clinic.
Eligibility| Ages Eligible for Study: | 19 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Participants in the study will be recruited from individuals receiving treatment at the Anxiety Disorders Clinic of UBC Hospital.
Inclusion Criteria:
- Patients referred to the Anxiety Disorders Clinic who receive a primary diagnosis of Obsessive Compulsive Disorder, and are accepted for treatment at the clinic.
Exclusion Criteria:
- Individuals who either have not sought treatment for anxiety at the Anxiety Disorders Clinic or patients who did not receive a primary diagnosis of Obsessive Compulsive Disorder.
Contacts and Locations| Canada, British Columbia | |
| Anxiety Disorders Clinic, University of British Columbia | |
| Vancouver, British Columbia, Canada, V6T 1Z9 | |
| Principal Investigator: | Maureen Whittal, Ph.D | University of British Columbia |
More Information
No publications provided
| Responsible Party: | Dr. Maureen Whittal, University of British Columbia |
| ClinicalTrials.gov Identifier: | NCT00457028 History of Changes |
| Other Study ID Numbers: | H03-80266 |
| Study First Received: | April 3, 2007 |
| Last Updated: | June 7, 2011 |
| Health Authority: | Canada: Health Canada |
Keywords provided by University of British Columbia:
|
Obsessive Compulsive Disorder Anxiety Treatment efficacy |
Additional relevant MeSH terms:
|
Obsessive-Compulsive Disorder Anxiety Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 21, 2013